CancerWorld’s 106 Issue: Bridging Innovation and Equity in Global Cancer Care
TheAugust 2025 issue of CancerWorld is now out, lighting up the intersection of scientific ingenuity and the urgent fight for equity in global cancer care. With a striking two-sided cover, this edition embodies the dual narrative driving progress today: breakthrough innovation and relentless advocacy for access.
On one side, Dr. Jennifer Buell tells the story of MiNK Therapeutics and its groundbreaking off-the-shelf iNKT cell therapy – a quiet revolution that’s remapping the immuno-oncology landscape and offering new hope to patients everywhere.
On the other, Jayasree K. Iyer, CEO of the Access to Medicine Foundation, issues a powerful challenge to the industry: while treatments evolve at lightning speed, 80% of the world still faces insurmountable barriers to care. Her perspective is both a rallying cry and a pragmatic roadmap for transforming innovation into equitable reality.
Inside, CancerWorld 106 unfolds with ten transformative stories:
-
AI’s Prognostic Frontier: How FaceAge leverages artificial intelligence to predict cancer survival outcomes from simple photographs, urging clinicians to rethink conventional prognostic markers.
-
A Life in Teaching, a Battle with Lymphoma: Prof. Michel Goldman’s journey from immunologist to patient offers lessons in resilience that transcend the bounds of medicine.
-
Trust and Tradition: An investigative look into how folk remedies still influence Eastern Europe’s cancer communities—highlighting the dangers of mistrust and the gaps in evidence-based care.
-
Cancer Neuroscience Breakthrough: Celebrating Professors Frank Winkler and Michelle Monje’s Brain Prize-winning discovery that neurons can ‘feed’ tumors, opening a bold new therapeutic avenue.
-
Survivor’s Voice: Sandy Duarte pens an open letter to oncologists, reminding the medical community that sometimes healing comes through empathy – a hug can heal as much as any drug.
-
Hidden Dangers: A clinical probe into the connection between BRCA mutations and breast-implant-associated lymphoma – critical knowledge for survivors and clinicians.
-
AI-Authored Reflection: Albertina, an AI, explores the delicate “art” of personalized hope, demonstrating that while algorithms guide, it is human connection that gives purpose.
-
Palliative Care Legacy: Honoring Dr. Anne Merriman, whose pioneering work in palliative care has transformed lives across Africa and set a standard for compassionate medicine.
-
Cancer Neuroscience Spotlight: Revisiting Winkler and Monje’s research, which has placed neuron-tumor interaction at the heart of the next era in brain cancer therapeutics.
-
Global Equity Call: Jayasree K. Iyer’s actionable vision to bridge the chasm between treatment advances and worldwide access.
This issue continues its tradition of combining cutting-edge science with human stories, policy analysis, and cultural insight, setting the agenda for where cancer care is heading next.
CancerWorld 106 doesn’t just highlight what’s newly possible in labs – it insists that real progress is measured by what we make possible for people everywhere.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023